Search Results 1051-1060 of 19873 for Receptor

  1. Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers

    “We tested Toll-like receptor (TLR) agonists — drugs that mimic invasive bacteria — as a strategy to trick the immune system into attacking cancer as if it ...

  2. Precision medicine for breast cancer - Care at Mayo Clinic

    Endoxifen, an estrogen receptor targeted therapy: From bench to bedside. Endocrinology. 2021; doi:10.1210/endocr/bqab191. Goetz MP, et al. Tumor sequencing ...

  3. Small lymphocytic lymphoma - Diagnosis and treatment - Mayo Clinic

    Chimeric antigen receptor (CAR)-T cell therapy trains the immune system ... The receptors help the cells recognize a marker on the surface of the lymphoma cells.

  4. Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant - Mayo Clinic

    Participant has a histologically and/or cytologically confirmed diagnosis of estrogen receptor positive (ER+) and/or progesterone receptor positive (PgR+) ...

  5. White coat hypertension: When blood pressure rises in a medical setting

    Alcohol: Does it affect blood pressure? Alpha blockers · Amputation and diabetes: How to protect your feet · Angiotensin II receptor blockers · Angiotensin ...

  6. Study of Ociperlimab in Combination With Tislelizumab in Advanced Solid Tumors - Mayo Clinic

    Patients with any prior therapy for recurrent/metastatic disease. 2. Non-squamous NSCLC patients with sensitizing epidermal growth factor receptor (EGFR)

  7. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

    receptor modified T-cell (CAR-T) therapy within 60 days of randomization - Clinically significant cardiovascular disease - Prolonged QT interval corrected ...

  8. Clinical and Translational Science - Tracks - Ph.D. Program in Biomedical Science - Mayo Clinic College of Medicine & Science

    “The Role of Glypican-3 Isoforms in the Development of Chimeric Antigen Receptor T Cells for Liver Cancer Therapy,” Aarti Koluri (Mentor: Lewis R. Roberts ...

  9. Study of bb2121 in Multiple Myeloma - Clinical Trials

    Preclinical studies suggest that bb2121, a chimeric antigen receptor (CAR) T-cell therapy that targets B-cell maturation antigen (BCMA), has potential for the ...

  10. Video: SCAD and COVID-19 - Spontaneous Coronary Artery Dissection (SCAD) Research Program

    ... receptor blockers (ARBs) as prescribed to treat heart failure, hypertension or diabetes. Read the video transcript. More about research at Mayo Clinic.